Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FLL | FULL HOUSE RESORTS INC | $115.16M | 35,875,647 | 42.99% | 57.01% | Net Buying | |||
| ATUS | ALTICE USA INC | $1.16B | 463,230,046 | 29.36% | 70.64% | Net Selling | Net Selling | ||
| IBKR | INTERACTIVE BROKERS GROUP INC | $18.99B | 108,931,614 | 84.62% | 15.38% | Net Buying | |||
| OTLY | OATLY GROUP AB | $336.09M | 598,559,840 | 13.35% | 0.00% | ||||
| SPB | SPECTRUM BRANDS HOLDINGS INC | $1.66B | 26,313,921 | 15.27% | 84.73% | Net Buying | |||
| BHVN | BIOHAVEN LTD | $2.29B | 102,054,499 | 82.85% | 17.15% | Net Buying | Net Buying | ||
| AIR | AAR CORP | $1.99B | 36,103,802 | 90.41% | 9.59% | Net Selling | Net Selling | ||
| IHS | IHS HOLDING LTD | $1.66B | 333,440,937 | 14.96% | 0.00% | ||||
| MSTR | MICROSTRATEGY INC | $98.21B | 257,351,857 | 41.04% | 0.06% | Net Selling | Net Buying | ||
| IPSC | CENTURY THERAPEUTICS INC | $47.75M | 86,045,033 | 42.30% | 45.63% | Net Selling | Net Selling | ||
| VYGR | VOYAGER THERAPEUTICS INC | $195.98M | 55,206,885 | 53.96% | 46.04% | Net Selling | Net Selling | ||
| ANAB | ANAPTYSBIO INC | $665.47M | 30,666,781 | 45.45% | 54.55% | Net Buying | Net Buying | ||
| CZR | CAESARS ENTERTAINMENT INC | $5.66B | 207,968,119 | 77.39% | 22.61% | Net Selling | Net Selling | ||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $17.71B | 1,133,838,689 | 58.60% | 0.82% | Net Selling | Net Selling | ||
| GANX | GAIN THERAPEUTICS INC | $60.58M | 27,786,952 | 7.14% | 4.69% | Net Buying | |||
| LRMR | LARIMAR THERAPEUTICS INC | $183.12M | 64,027,892 | 53.68% | 46.32% | ||||
| WVE | WAVE LIFE SCIENCES LTD | $1.22B | 153,486,021 | 66.33% | 33.67% | Net Buying | Net Buying | ||
| EXOD | EXODUS MOVEMENT INC | $1.15B | 28,598,615 | 0.03% | 7.98% | Net Selling | Net Selling | ||
| ICUI | ICU MEDICAL INC | $3.36B | 24,519,000 | 70.72% | 29.28% | Net Selling | Net Selling | ||
| XNCR | XENCOR INC | $765.22M | 70,461,934 | 70.29% | 29.71% | Net Selling | Net Selling | ||
| TSHA | TAYSHA GENE THERAPIES INC | $494.05M | 205,001,632 | 81.51% | 15.27% | Net Buying | Net Selling | ||
| NKTR | NEKTAR THERAPEUTICS | $145.16M | 186,103,588 | 71.41% | 14.11% | Net Selling | Net Selling | ||
| AARD | AARDVARK THERAPEUTICS INC | $245.81M | 21,695,920 | 0.00% | 46.82% | Net Buying | Net Buying | ||
| HPE | HEWLETT PACKARD ENTERPRISE CO | $21.56B | 1,313,578,244 | 82.19% | 0.53% | Net Buying | Net Buying | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $115.09M | 228,356,290 | 41.22% | 58.78% | Net Buying | Net Selling | ||
| IRON | DISC MEDICINE INC | $1.72B | 34,569,042 | 50.85% | 49.15% | Net Buying | Net Selling | ||
| FBRT | FRANKLIN BSP REALTY TRUST INC | $933.14M | 82,214,630 | 61.41% | 1.73% | Net Selling | |||
| ALIT | ALIGHT INC | $2.82B | 543,089,630 | 76.71% | 23.29% | Net Selling | Net Selling | ||
| LTRX | LANTRONIX INC | $84.56M | 38,789,664 | 7.28% | 92.72% | Net Selling | Net Buying | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $102.71M | 25,871,549 | 61.00% | 10.44% | Net Buying | |||
| ERAS | ERASCA INC | $422.07M | 283,265,716 | 72.86% | 27.14% | Net Buying | |||
| ARVN | ARVINAS INC | $497.22M | 68,771,867 | 77.41% | 22.59% | Net Selling | Net Selling | ||
| SANA | SANA BIOTECHNOLOGY INC | $427.55M | 225,024,899 | 52.63% | 47.37% | Net Selling | Net Selling | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | $3.13B | 174,973,806 | 45.63% | 54.37% | Net Selling | Net Selling | ||
| CSTL | CASTLE BIOSCIENCES INC | $550.61M | 28,514,109 | 85.52% | 14.48% | Net Selling | Net Selling | ||
| ONEW | ONEWATER MARINE INC | $223.98M | 16,313,115 | 55.02% | 44.98% | Net Buying | Net Buying | ||
| KAPA | KAIROS PHARMA LTD | $13.10M | 16,693,306 | 2.44% | 40.60% | Net Buying | |||
| USM | UNITED STATES CELLULAR CORP | $5.85B | 85,000,000 | 16.25% | 1.07% | Net Selling | Net Selling | ||
| CLMT | CALUMET INC | $921.55M | 86,207,118 | 26.18% | 73.82% | Net Selling | Net Selling | ||
| QCRH | QCR HOLDINGS INC | $1.10B | 16,901,169 | 73.71% | 11.41% | Net Buying | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $77.41M | 89,704,194 | 81.14% | 1.29% | ||||
| TARA | PROTARA THERAPEUTICS INC | $127.22M | 36,767,465 | 48.52% | 51.48% | Net Selling | Net Selling | ||
| BXC | BLUELINX HOLDINGS INC | $511.50M | 8,022,223 | 44.06% | 55.94% | Net Selling | |||
| NKTX | NKARTA INC | $145.46M | 70,957,554 | 63.76% | 36.24% | Net Selling | |||
| CEVA | CEVA INC | $627.31M | 23,806,655 | 67.47% | 32.53% | Net Buying | Net Buying | ||
| AKA | AKA BRANDS HOLDING CORP | $81.27M | 10,693,150 | 4.14% | 95.86% | ||||
| INSE | INSPIRED ENTERTAINMENT INC | $196.67M | 26,904,832 | 36.62% | 63.38% | Net Selling | |||
| PRO | PROS HOLDINGS INC | $801.51M | 47,567,581 | 45.05% | 54.95% | Net Buying | Net Buying | ||
| CGTX | COGNITION THERAPEUTICS INC | $27.70M | 61,972,946 | 17.86% | 41.09% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $282.85M | 77,492,959 | 35.72% | 64.28% | Net Buying | Net Buying | ||
| PCVX | VAXCYTE INC | $4.54B | 128,761,622 | 87.56% | 12.44% | Net Selling | Net Buying | ||
| OKUR | ONKURE THERAPEUTICS INC | $33.59M | 13,435,826 | 34.13% | 65.87% | Net Buying | Net Selling | ||
| TRVI | TREVI THERAPEUTICS INC | $667.11M | 96,682,229 | 30.28% | 69.72% | Net Buying | Net Buying | ||
| CYBN | CYBIN INC | $132.41M | 20,001,406 | 34.58% | 0.00% | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $126.53M | 32,195,345 | 44.49% | 55.51% | Net Selling | |||
| EVH | EVOLENT HEALTH INC | $1.16B | 116,591,148 | 88.98% | 11.02% | Net Selling | Net Selling | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $91.99M | 12,232,228 | 46.25% | 53.75% | Net Buying | Net Selling | ||
| ETNB | 89BIO INC | $1.19B | 145,984,182 | 83.07% | 11.12% | Net Buying | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $972.74M | 49,004,425 | 44.92% | 55.08% | Net Selling | Net Selling | ||
| ASUR | ASURE SOFTWARE INC | $264.94M | 26,979,485 | 54.45% | 45.55% | Net Buying | Net Selling | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $361.48M | 68,333,065 | 74.06% | 25.94% | Net Selling | |||
| LVRO | LAVORO LTD | $312.51M | 116,608,329 | 3.14% | 1.49% | ||||
| LXEO | LEXEO THERAPEUTICS INC | $156.36M | 33,196,997 | 80.55% | 19.45% | Net Selling | Net Buying | ||
| TNGX | TANGO THERAPEUTICS INC | $152.43M | 108,107,890 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| VERA | VERA THERAPEUTICS INC | $1.51B | 63,748,290 | 66.31% | 33.69% | Net Selling | Net Selling | ||
| HUT | HUT 8 CORP | $1.40B | 103,855,686 | 49.15% | 10.34% | Net Buying | Net Buying | ||
| KLC | KINDERCARE LEARNING COMPANIES INC | $1.47B | 118,006,276 | 56.98% | 43.02% | Net Selling | Net Selling | ||
| BNTX | BIONTECH SE | $24.58B | 239,970,804 | 21.14% | 0.00% | ||||
| DSP | VIANT TECHNOLOGY INC | $908.26M | 63,073,761 | 11.51% | 88.49% | Net Selling | Net Selling | ||
| FVR | FRONTVIEW REIT INC | $334.15M | 27,822,663 | 58.78% | 16.61% | Net Selling | Net Buying | ||
| GHRS | GH RESEARCH PLC | $560.34M | 52,028,145 | 59.00% | 0.00% | ||||
| CLAR | CLARUS CORP | $126.60M | 38,362,162 | 58.91% | 25.00% | Net Buying | Net Buying | ||
| SSYS | STRATASYS LTD | $677.72M | 71,716,159 | 53.54% | 0.00% | ||||
| IMVT | IMMUNOVANT INC | $2.70B | 169,860,683 | 44.70% | 55.30% | Net Buying | Net Selling | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $1.80B | 133,184,349 | 90.38% | 9.62% | Net Selling | Net Selling | ||
| PONY | PONY AI INC | $3.00B | 350,292,553 | 28.28% | 0.00% | ||||
| BNTC | BENITEC BIOPHARMA INC | $337.94M | 23,451,475 | 81.01% | 8.93% | Net Buying | Net Buying | ||
| PVLA | PALVELLA THERAPEUTICS INC | $265.44M | 11,018,747 | 36.60% | 56.31% | Net Buying | Net Buying | ||
| AKRO | AKERO THERAPEUTICS INC | $3.61B | 79,620,128 | 70.71% | 29.29% | Net Buying | Net Buying | ||
| CRDF | CARDIFF ONCOLOGY INC | $180.28M | 66,524,294 | 42.19% | 25.47% | Net Buying | |||
| OFIX | ORTHOFIX MEDICAL INC | $528.75M | 39,022,492 | 84.69% | 14.45% | Net Buying | Net Buying | ||
| KYTX | KYVERNA THERAPEUTICS INC | $95.94M | 43,214,918 | 56.40% | 43.60% | Net Buying | |||
| APGE | APOGEE THERAPEUTICS INC | $2.33B | 59,503,184 | 90.99% | 9.01% | Net Selling | Net Selling | ||
| IVA | INVENTIVA SA | $334.82M | 95,662,391 | 5.69% | 0.00% | ||||
| COYA | COYA THERAPEUTICS INC | $105.03M | 16,724,998 | 26.57% | 12.80% | Net Buying | |||
| HLLY | HOLLEY INC | $271.16M | 121,052,686 | 13.46% | 86.54% | Net Selling | Net Selling | ||
| REPL | REPLIMUNE GROUP INC | $742.42M | 77,014,781 | 65.10% | 34.90% | Net Selling | |||
| CBNA | CHAIN BRIDGE BANCORP INC | $160.44M | 6,561,817 | 18.60% | 10.22% | Net Buying | Net Buying | ||
| PENG | PENGUIN SOLUTIONS INC | $907.69M | 53,677,557 | 66.45% | 33.55% | Net Selling | Net Selling | ||
| AVNW | AVIAT NETWORKS INC | $233.51M | 12,683,983 | 68.46% | 31.54% | Net Selling | |||
| XYZ | BLOCK INC | $35.97B | 615,019,000 | 64.58% | 5.23% | Net Buying | Net Selling | ||
| VERV | VERVE THERAPEUTICS INC | $488.38M | 88,795,768 | 63.38% | 36.62% | Net Buying | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $66.33M | 27,072,129 | 77.00% | 23.00% | Net Buying | |||
| CYRX | CRYOPORT INC | $272.51M | 49,910,391 | 94.80% | 3.71% | Net Buying | Net Selling | ||
| RCUS | ARCUS BIOSCIENCES INC | $912.35M | 105,841,422 | 59.71% | 40.29% | Net Buying | Net Buying | ||
| TSEM | TOWER SEMICONDUCTOR LTD | $4.06B | 111,550,761 | 62.83% | 0.00% | ||||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $27.55M | 53,384,145 | 73.37% | 26.63% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.